-
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared ...
PARIS, May 23, 2013 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), the leader in embolic protection stents, today announced new 6-month results from ...
PR Newswire via Yahoo! Canada Finance -
InspireMD Announces Reimbursement Coverage for MGuard™ Coronary
BOSTON and TEL AVIV, Israel, May 16, 2013 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, today announced that ...
PR Newswire via Yahoo! Finance -
InspireMD to Announce Six-Month Results from the MGuard™ Embolic Protection Stent (EPS) MASTER Trial at EuroPCR
BOSTON and TEL AVIV, Israel, May 16, 2013 /PRNewswire/ -- - Strong Conference Presence to Include Presentations/Educational Events Featuring the MGuard™ Embolic Protection Stent- - Company to Host ...
PR Newswire via Yahoo! Finance -
InspireMD Announces Reimbursement Coverage for MGuard™ Coronary Embolic Protection Stent (EPS) From Brazil's Largest ...
BOSTON and TEL AVIV, Israel, May 16, 2013 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, today announced that ...
PR Newswire via Yahoo! Finance -
InspireMD Reports Financial Results For Period Ended March 31, 2013
BOSTON and TEL AVIV, Israel, May 8, 2013 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, today announced financial ...
PR Newswire via Yahoo! Finance -
InspireMD receives reimbursement approval for MGuard from UNIMED
InspireMD announced that it received reimbursement approval for the MGuard Coronary Embolic Protection Stent from UNIMED, Brazil's largest private health care insurer.
Theflyonthewall.com via Yahoo! Finance -
InspireMD initiated with an Outperform at Cowen
08:40 EDT InspireMD initiated with an Outperform at Cowen
Theflyonthewall.com via Yahoo! Finance -
InPlay from Briefing.com
InPlay from Briefing.com
Briefing.com via Yahoo! Finance -
Insiders Buy Shares at General Electric and Gain Capital
Insiders Buy Shares at General Electric and Gain Capital
Nasdaq -
HALO Shines, NSPR Inspires, SCMP, SNY, ACOR, ISIS Hit Highs, Can CLSN Resurrect?
Celsion Corp., which took a hit in January of this year, losing over 80% of its stock value, after a phase III trial of its investigational liver cancer treatment ThermoDox failed to meet the primary endpoint of progression free survival, still has hopes on ThermoDox.
RTT News